| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC3517 |
| Trial ID | NCT05952375 |
| Disease | Gastric Cancer |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | XKDCT086 |
| Phase | Not Applicable |
| Recruitment status | Recruiting |
| Title | Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial |
| Year | 2023 |
| Country | China |
| Company sponsor | The Affiliated Hospital of Qingdao University |
| Other ID(s) | XKDCT086 |
| Cohort 1 | |||||||||
|
|||||||||